Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. is grouped at the issuer level across 1 linked ticker lifecycle, combining public listing, delisting, source, and shareholder outcome records from the archive.
Lifecycle Map
Issuer enters the archive
Jun 3, 2016Syros Pharmaceuticals, Inc. is represented as an issuer-level entity with 1 linked public-market ticker lifecycle.
Delisting event
Mar 10, 2025Removed from listing - SEC Form 25 filed.
SourceSYRS stopped trading
Mar 10, 2025SYRS is linked to Syros Pharmaceuticals, Inc. and ended with final status "delisted".
Source
Entity Graph
Syros Pharmaceuticals, Inc.issuedSYRS
SYRSlisted onNASDAQ
SYRSresulted inmixed
Source-Backed Claims
- Syros Pharmaceuticals, Inc. entered into a letter agreement with Oxford Finance LLC on February 28, 2025.8-K
- The letter agreement addressed the repayment of all amounts owed under the loan and security agreement dated February 12, 2020.8-K
- The total payoff amount agreed upon was approximately $6,000,000, to be paid in cash and other non-cash assets.8-K
- Upon payment of the Payoff Amount, Syros Pharmaceuticals, Inc.'s indebtedness under the Loan Agreement was deemed paid and discharged in full.8-K
- The Collateral Agent and the Lenders agreed to apply any cash proceeds from non-cash assets toward the remainder of the Payoff Amount.8-K
- Any cash proceeds exceeding the remainder of the Payoff Amount were to be reassigned to the Company, and the excess returned to Syros Pharmaceuticals, Inc.8-K
Associated Tickers
Public-market security lifecycles tied to this issuer record.